| Company Name: |
LETOPHARM LIMITED
|
| Tel: |
+86-21-5821 5861 |
| Email: |
sales@letopharm.com |
| Products Intro: |
Product Name:NMS-P715 (analog)
CAS:1202055-34-2
|
|
| | NMS-P715 Basic information |
| Product Name: | NMS-P715 | | Synonyms: | NMS-P715;N-(2,6-diethylphenyl)-1-Methyl-8-({4-[(1-Methylpiperidin-4-yl)carbaMoyl]-2-(trifluoroMethoxy)phenyl}aMino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxaMide;NMS P715 analog;NMS-P 715 analog;NMS-P715 analog;N-(2,6-diethylphenyl)-1-methyl-8-((4-((1-methylpiperidin-4-yl)carbamoyl)-2-(trifluoromethoxy)phenyl)amino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide NMS-P715;1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, N-(2,6-diethylphenyl)-4,5-dihydro-8-[[2-methoxy-4-[[(1-methyl-4-piperidinyl)amino]carbonyl]phenyl]amino]-1-methyl-;NMS P715 ANALOG;NMS-P 715 ANALOG | | CAS: | 1202055-34-2 | | MF: | C35H42N8O3 | | MW: | 622.76 | | EINECS: | | | Product Categories: | | | Mol File: | 1202055-34-2.mol |  |
| | NMS-P715 Chemical Properties |
| density | 1.32±0.1 g/cm3(Predicted) | | solubility | Soluble in DMSO | | form | Powder | | pka | 11.75±0.70(Predicted) |
| | NMS-P715 Usage And Synthesis |
| | NMS-P715 Preparation Products And Raw materials |
|